Literature DB >> 18815047

Needle in the haystack: structure-based toxin discovery.

Robert J Fieldhouse1, A Rod Merrill.   

Abstract

In the current data-rich era, making the leap from sequence data to knowledge is a task that requires an elegant bioinformatics toolset to pinpoint pressing research questions. Therefore, a strategy to expand important protein-family knowledge is required, particularly in cases in which primary sequence identity is low but structural conservation is high. For example, the mono-ADP-ribosylating toxins fit these criteria and several approaches have been used to accelerate the discovery of new family members. The strategy evolved from conduction of PSI-BLAST searches through to the combination of secondary-structure prediction with pattern-based searches. However, a newly developed tactic, in which fold recognition dominates, reduces reliance on sequence similarity and advances scientists toward a true structure-based protein-family expansion methodology.

Mesh:

Substances:

Year:  2008        PMID: 18815047     DOI: 10.1016/j.tibs.2008.08.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  26 in total

Review 1.  Targeting of the actin cytoskeleton by insecticidal toxins from Photorhabdus luminescens.

Authors:  Alexander E Lang; Gudula Schmidt; Joel J Sheets; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-11-12       Impact factor: 3.000

2.  Structure function analysis of an ADP-ribosyltransferase type III effector and its RNA-binding target in plant immunity.

Authors:  Byeong-ryool Jeong; Yan Lin; Anna Joe; Ming Guo; Christin Korneli; Huirong Yang; Ping Wang; Min Yu; Ronald L Cerny; Dorothee Staiger; James R Alfano; Yanhui Xu
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

3.  C3larvin toxin, an ADP-ribosyltransferase from Paenibacillus larvae.

Authors:  Daniel Krska; Ravikiran Ravulapalli; Robert J Fieldhouse; Miguel R Lugo; A Rod Merrill
Journal:  J Biol Chem       Date:  2014-12-04       Impact factor: 5.157

4.  Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae.

Authors:  Argentina Becker; T R Kannan; Alexander B Taylor; Olga N Pakhomova; Yanfeng Zhang; Sudha R Somarajan; Ahmad Galaleldeen; Stephen P Holloway; Joel B Baseman; P John Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

5.  Strain-alleviation model of ADP-ribosylation.

Authors:  Thomas Jank; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-01       Impact factor: 11.205

6.  Scabin, a Novel DNA-acting ADP-ribosyltransferase from Streptomyces scabies.

Authors:  Bronwyn Lyons; Ravikiran Ravulapalli; Jason Lanoue; Miguel R Lugo; Debajyoti Dutta; Stephanie Carlin; A Rod Merrill
Journal:  J Biol Chem       Date:  2016-03-21       Impact factor: 5.157

7.  Diverse NADase effector families mediate interbacterial antagonism via the type VI secretion system.

Authors:  Jenny Y Tang; Nathan P Bullen; Shehryar Ahmad; John C Whitney
Journal:  J Biol Chem       Date:  2017-12-13       Impact factor: 5.157

8.  Photox, a novel actin-targeting mono-ADP-ribosyltransferase from Photorhabdus luminescens.

Authors:  Danielle D Visschedyk; Alexandru A Perieteanu; Zachari J Turgeon; Robert J Fieldhouse; John F Dawson; A Rod Merrill
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

9.  Concept and application of a computational vaccinology workflow.

Authors:  Johannes Söllner; Andreas Heinzel; Georg Summer; Raul Fechete; Laszlo Stipkovits; Susan Szathmary; Bernd Mayer
Journal:  Immunome Res       Date:  2010-11-03

10.  Characterization of an actin-targeting ADP-ribosyltransferase from Aeromonas hydrophila.

Authors:  Adin Shniffer; Danielle D Visschedyk; Ravikiran Ravulapalli; Giovanni Suarez; Zachari J Turgeon; Anthony A Petrie; Ashok K Chopra; A Rod Merrill
Journal:  J Biol Chem       Date:  2012-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.